Related Experiment Video

Updated: Nov 23, 2025

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
06:39

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice

Published on: April 13, 2015

15.3K

Correlation between growth differentiation factor-15 and the severity of chronic heart failure in patients with

H Du1, L Yang, H Zhang

  • 1Department of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. duhong@hb2h.com.

European Review for Medical and Pharmacological Sciences
|December 30, 2020
PubMed

Insights

Growth Differentiation Factor-15 (GDF-15) levels correlate with chronic heart failure (CHF) severity in coronary atherosclerosis patients. This finding suggests GDF-15 is a potential biomarker for assessing CHF progression and guiding treatment strategies.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Research

Background:

  • Coronary atherosclerosis is a leading cause of chronic heart failure (CHF).
  • Identifying reliable biomarkers for CHF severity is crucial for effective patient management.
  • Growth Differentiation Factor-15 (GDF-15) is a cytokine implicated in various stress-related conditions.

Purpose of the Study:

  • To investigate the association between Growth Differentiation Factor-15 (GDF-15) levels and the severity of chronic heart failure (CHF).
  • To determine if GDF-15 can serve as a predictive biomarker for CHF severity in patients with coronary atherosclerosis.

Main Methods:

  • Retrospective analysis of 300 coronary atherosclerosis patients with CHF and 300 healthy controls.
  • Collection of clinical data including demographics, lifestyle factors, and biochemical markers (GDF-15, cystatin C, CRP).
  • Classification of heart failure severity and statistical analysis to assess correlations.

Main Results:

  • No significant differences in basic clinical information between patient and control groups.
  • Significant differences in GDF-15, cystatin C, and CRP levels were observed across different CHF severity grades.
  • Elevated GDF-15 levels were noted in patients with higher CHF severity (Grade IV vs. Grade I).

Conclusions:

  • GDF-15 levels are significantly correlated with the severity of chronic heart failure in patients with coronary atherosclerosis.
  • GDF-15 emerges as a potential biomarker for evaluating CHF severity.
  • These findings offer insights into the biological mechanisms and potential therapeutic targets for heart failure.
Abstract

More Related Videos

Histological Quantification of Chronic Myocardial Infarct in Rats09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

15.0K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.6K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
140
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
248
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
163
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
280
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
155